# RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)

> **NCT00830895** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 49 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** RAD001

## Key facts

- **NCT ID:** NCT00830895
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-10
- **Final completion:** 2012-12
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2022-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830895, "RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00830895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*